Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07376577Recruiting
Randomised, double-blind trial of tagileridine in sedation (3 arms), sponsored by Xinxiang Medical University First Affiliated Hospital. Primary endpoints: Intraoperative Pain Control Success Rate and Incidence of respiratory depression. Started Jan 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07376577.